Skip to content
Hit enter to search or ESC to close
EN
TH
About PReMA
Who is PReMA
IFPMA
PReMA members
Inspiration
Crack the mindset
Webinar
The standard
Library
Drug diagnosis and development
General knowledge
Relevant Resources
Ethics
Ethics
Accreditation Program
Contact Us
Pharma By Number
Pharma By Number
PHARMA BY NUMBER
Industry spend 141.6 Billion USD on R&D per year
Drug Development for Particular Disease
o Cancer 1,813
o Diabetes 475
o HIV/AIDS 159
o Cardiovascular 559
5 of the 10 Leading global R&D firms were Research – Base Biopharmaceutical companies
Annual Spending by the Biopharmaceutical: Industry is 5 times greater than the Defence & Aerospace Industries
PHARMA & GLOBAL HEALTH BETWEEN 2000-2008
VACCINE HELPED REDUCE NUMBER OF MEASLES DEATH IN AFRICA BY 92%
IN 2014 IFPMA MEMBERS HAD 186 ONGOING R&D PROJECTS REGARDING DIEASES OF THE DEVELOPING WORLD
88% R&D projects for NTDs are in partnerships between IFPMA members companies and +80 partners from universities, public and private sector, and NGOs
We are 3 largest global funder in NTDs research
Our investments in NTD research reached USD 401.2 million in 2013
8 R&D centers are dedicated solely to searching for new cures for NTDs
500 million immunized since 2000
PHARMA ECONOMIC FOOTPRINT
Biopharmaceutical market will reach 1.3 trillion by 2018
In 2012, Biopharmaceutical industry added USD 436.8 Billion to the world GDP similar to the economy of a country like Argentina
The Global biopharmaceutical industry (including Generic) employed over 4.4 million and paid USD 91.3 Billion in salaries
Global Health Partnerships IFPMA members have a strong track record in building strategic alliances for global health
408/85, 19th Floor, Phaholyothin Place Bldg., Phaholyothin Road, Samsennai, Phayathai, Bangkok 10400 Thailand
Phone : (02) 619-0232-6
Fax : (02) 619-0237
Email : office@prema.or.th
facebook.com/prem.health
PReMA Thailand